Aidigong Maternal & Child Health Limited (HKG:0286)
Hong Kong
· Delayed Price · Currency is HKD 1.310
-0.010 (-0.76%)
Feb 21, 2025, 9:42 AM HKT
HKG:0286 Revenue
Aidigong Maternal & Child Health had revenue of 274.74M HKD in the half year ending June 30, 2024, a decrease of -16.44%. This brings the company's revenue in the last twelve months to 522.09M, down -20.70% year-over-year. In the year 2023, Aidigong Maternal & Child Health had annual revenue of 554.58M, down -18.44%.
Revenue (ttm)
522.09M
Revenue Growth
-20.70%
P/S Ratio
0.48
Revenue / Employee
390.20K
Employees
1,311
Market Cap
251.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 554.58M | -125.37M | -18.44% |
| Dec 31, 2022 | 679.95M | 37.37M | 5.82% |
| Dec 31, 2021 | 642.57M | 41.36M | 6.88% |
| Dec 31, 2020 | 601.21M | -9.40M | -1.54% |
| Dec 31, 2019 | 610.61M | 233.58M | 61.95% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Alibaba Health Information Technology | 31.39B |
| Sino Biopharmaceutical | 30.72B |